Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.01, read 2026-10-27
Ethical passes the values gate
Price6.68 USD
Fair value10.00
Ethical score70.0/100
Our investment reviews on this name
2026-10-11Read Markup5.38+24.2% to today ✓Distribution gives way to Markup first Markup read since August
2026-10-02Read Distribution5.38+24.2% to today Markup gives way to Distribution after a 20% slide in 5 weeks
2026-08-26Read Markup6.74-0.9% to today Accumulation gives way to Markup after a 16% rise in 4 weeks
2026-07-26Read Accumulation5.83+14.6% to today ✓Markup gives way to Accumulation after a 9% rise in 3 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Sprinklr, Inc. holds its Accumulation at $6.68. Consolidating, no directional conviction, held for 15 days.
As held on the ledger · 2026-10-27
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 15 days
Price at the screen
$6.68
Valuation
74.56 trailing · 12.55 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.77
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
3.88%
Below 33%
Interest-bearing debt is just 3.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
28.18%
Below 33%
Cash held in interest-bearing accounts and securities is 28.2% of assets, under the one-third limit.
Pass
Receivables
36.60%
Below 49%
Money owed to the company is 36.6% of assets, under the 49% limit.
Pass
Revenue purity
2.36%
Below 5%
Only 2.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Sprinklr, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 4%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CXM's ethical verdict changes
Today CXM passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 49.0% margin of safety to the base estimate.
Third-party analyst targets: 8 covering, consensus None. The average target sits +20% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Sprinklr Software Shows Too Little Momentum to Matter
When big companies need one platform to handle customer messages across every channel, Sprinklr sounds like a useful tool. Yet revenue is rising only 7 percent, profit margins sit at 3 percent and return on equity is just 5 percent. We pass because these numbers show a business without the growth or returns that would make it worth following.
The forward multiple of 10.7 times earnings looks modest against our fair value of 8.44 dollars from a current price of 5.83. Analyst targets sit at a median of 7 dollars with no clear rating, and the moat stays unknown. Ethical screen passes, but that alone does not create an opportunity.
Low profitability leaves little buffer if competition intensifies or clients delay spending. Even a wide gap to fair value can stay unrealised when capital returns remain this weak for years.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CXM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Markup$5.85+0.0%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (8 analysts) rates it none, with a mean price target of $8.
2026-10-18Markup$5.85+8.7%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (8 analysts) rates it none, with a mean price target of $8.
2026-10-11Markup · changed$5.38+0.0%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (8 analysts) rates it none, with a mean price target of $8.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (8 analysts) rates it none, with a mean price target of $8. Since the last review it entered the Tech 100; its composite score rose.
2026-08-26Markup · changed$6.74+15.6%Entry 5
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 15.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (8 analysts) rates it none, with a mean price target of $8.
2026-07-26Accumulation · changed$5.83+9.2%Entry 4
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (8 analysts) rates it none, with a mean price target of $8.
2026-07-18Markup$5.34+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 38%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (8 analysts) rates it none, with a mean price target of $8.
2026-07-03Markup$5.34+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$5.34Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
